Previous Article | Next Article 
Journal of Virology, December 2001, p. 12331-12338, Vol. 75, No. 24
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.12331-12338.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of BV/ODV-C42, an Autographa
californica Nucleopolyhedrovirus orf101-Encoded
Structural Protein Detected in Infected-Cell Complexes with
ODV-EC27 and p78/83
Sharon C.
Braunagel,1,2
Paula A.
Guidry,1,2
German
Rosas-Acosta,1,2
Luke
Engelking,3 and
Max D.
Summers1,2,3,*
Texas Agricultural Experiment
Station,1 Department of
Entomology,2 and Department of
Biochemistry and Biophysics,3 Texas A&M
University, College Station, Texas 77843-2475
Received 12 June 2001/Accepted 19 September 2001
 |
ABSTRACT |
orf101 is a late gene of Autographa
californica nucleopolyhedrovirus (AcMNPV). It
encodes a protein of 42 kDa which is a component of the nucleocapsid of
budded virus (BV) and occlusion-derived virus (ODV). To reflect this
viral localization, the product of orf101 was named
BV/ODV-C42 (C42). C42 is predominantly detected within the
infected-cell nucleus: at 24 h postinfection (p.i.), it is
coincident with the virogenic stroma, but by 72 h p.i., the stroma
is minimally labeled while C42 is more uniformly located throughout the
nucleus. Yeast two-hybrid screens indicate that C42 is capable of
directly interacting with the viral proteins p78/83
(1629K) and ODV-EC27 (orf144). These
interactions were confirmed using blue native gels and Western blot
analyses. At 28 h p.i., C42 and p78/83 are detected in two
complexes: one at approximately 180 kDa and a
high-molecular-mass complex (500 to 600 kDa) which also contains EC27.
 |
INTRODUCTION |
Occlusion-derived virus (ODV)
of Autographa californica nucleopolyhedrovirus
(AcMNPV) initiates primary infection through gut cells of
the susceptible insect, where the columnar cells are the primary sites
of infection (13, 31). Columnar cells, however, are in a
differentiated state (7). Thus, AcMNPV must have the ability to progress the infected columnar cell from
G0 to G1 and further
progress the cell to a phase conducive to viral DNA replication (S
phase). These events occur rapidly: in virus-challenged Trichoplusia ni larvae, midgut infection is detectable by
4 h postinoculation and systemic infection is detected by 12 h (31).
Viral regulation of the host cell cycle could be accomplished through
several mechanisms. One mechanism is the early
transcription-translation of viral genes which interact with
cellular proteins or protein complexes. Some evidence suggests that
AcMNPV may be utilizing this mechanism. The ie-2
gene is sufficient to arrest transfected Sf9 cells in S phase: the
arrested cells do not undergo mitosis, have abnormally large nuclei,
and contain greater than 4N DNA content (19). Infected Sf9
cells, however, show only a transient increase of cells in S phase, and
the cells quickly progress to G2/M phase, where
they remain arrested throughout infection (4). A second
viral strategy to regulate the host cell cycle is to present, as
structural components of the virus, a protein(s) or protein complexes
that interact with cellular proteins immediately upon infection. For
AcMNPV, the structural protein ODV-EC27 (EC27) is a
candidate for such a strategy: it has amino acid similarity with
cellular cyclins, and it coprecipitates with cellular cyclin kinases
(1, 4). Its introduction into the cell at the time of
infection may allow it to interact immediately with cellular cyclin
kinases or function as a cyclin homologue in a manner analogous to that
of other viral cyclin homologues. In our continuing study of the
function of AcMNPV structural proteins and their
interactions with host cell proteins, we have identified a new
structural protein of budded virus (BV) and ODV, BV/ODV-C42 (C42;
orf101), and show that this protein is present in complexes
that also contain the viral proteins EC27 and p78/83.
 |
MATERIALS AND METHODS |
Insect cell line and virus.
Spodoptera frugiperda
IPLB-Sf21-AE clonal isolate 9 (Sf9) cells were cultured in suspension
at 27°C in TNMFH medium (26) supplemented with 10%
fetal bovine serum and 1% pluronic F68 (complete medium).
AcMNPV (strain E2) was used to infect cells at a defined multiplicity of infection (MOI), with time zero set at the time of
virus addition. After 1 h of adsorption, cells were washed and
resuspended in fresh, complete medium.
Primer extension.
Sf9 cells were infected (MOI, 10), and
mRNA was purified using the Poly(A)Pure mRNA isolation kit (Ambion,
Inc., Austin, Tex.). Two oligonucleotides (PE1,
5'-GCATAGGCTCGTCTATTTTTAACCGC-3'; PE2, GTCTAACACGTTGACCGTTTCG) were 5' end labeled with
T4 polynucleotide kinase and probed against 3 µg of cellular mRNA. Extension products were generated using
Superscript II reverse transcriptase (Life Technologies, Gaithersburg,
Md.) in the presence of 2.3 µg of actinomycin D, 28 U of RNasin, and
0.5 mM deoxynucleoside triphosphates for 60 min at 45°C and then
precipitated and digested with 0.1 N NaOH for 30 min at room
temperature, resuspended in 80% formamide loading buffer, and boiled
for 3 min before being loaded onto a denaturing gel (7.0 M urea, 6%
polyacrylamide, 100 mM Tris-borate, 20 mM EDTA, pH 8.3). Transcript
initiation sites were identified by comparison with a DNA sequence by
using the same oligonucleotide primers as used for generating the
extension products and run concurrently on the denaturing gel with the
extension products.
Western blot analysis of infected cells, virus, and virus
fractionation.
Sf9 cells were infected with AcMNPV
(MOI, 10), and at the indicated time postinfection (p.i.), cells were
collected and washed once with phosphate-buffered saline (PBS). Cell
pellets were resuspended in PBS containing protease inhibitors (20 µg
of leupeptin/ml, 20 µg of aprotinin/ml, 20 µg of pepstatin A/ml, 1 mM E64). Cells were broken by sonication, and protein concentration was
determined by the method of Bradford (3).
BV was purified from the cell culture supernatant of infected cells (36 h p.i.) by the technique described in the work of Braunagel and Summers
(5). Occlusions were purified from infected Sf9 cells by a
modified technique of Summers and Egawa (25) and Braunagel
and Summers (5). The occlusions were then purified from
the pellet by using sucrose gradients as described in the work of
Braunagel and Summers (5). ODV was purified from
occlusions, and purified BV and ODV were fractionated into envelope and
nucleocapsid preparations according to the method described in the work
of Braunagel and Summers (5). The purified virus and viral
fractions were analyzed using known viral markers (p39, E66, and gp67)
to verify purity.
Vertical slab gel electrophoresis was performed according to the method
of Laemmli (14). A 4% stacking gel was used above a
12.5% separating gel. Samples were incubated in 1.5% sodium dodecyl
sulfate (SDS)-0.5%
-mercaptoethanol-25 mM Tris-HCl (pH 6.8)-7%
glycerol for 15 min at 65°C before loading and separated by
electrophoresis. Western analysis was performed using protein blotted
onto polyvinylidene difluoride (PVDF) membranes (Immobilon-P; Millipore, Bedford, Mass.). The membranes were blocked, and antibody binding was performed in TTBS-BLOTTO (150 mM NaCl, 10 mM Tris, 1 to 3%
nonfat dry milk, 0.1% Tween 20, pH 8.0). Primary antibody was bound
overnight, blots were washed three times (TTBS), and secondary antibody
(anti-rabbit, horseradish peroxidase-linked immunoglobulin G [IgG])
was reacted for 1 h (1:10,000; room temperature). Blots were
washed three times with Tris-buffered saline (15 min) and treated for 1 min with Renaissance chemiluminescence reagent (NEN Life Science
Products, Boston, Mass.), and a positive reaction was detected by
exposure to X-ray film.
Yeast two-hybrid library construction and screen.
Sf9 cells
were infected (MOI, 20), and at 18 or 24 h p.i., cells were
collected and mRNA was isolated by using either the Poly A Tract System
1000 (Promega, Madison, Wis.) or the Poly(A)Pure mRNA isolation kit
(Ambion). The cDNA library was generated using the Two Hybrid cDNA
Construction kit (Clontech, Palo Alto, Calif.), and thus, the genomic
fragments were cloned into the vector pGAD10. The libraries were
amplified, and the resulting titers of the amplified libraries were as
follows: at 18 h p.i., 1.31 × 1012,
and at 24 h p.i., 3.25 × 1013. To
harvest large quantities of DNA from each library, a 1-ml aliquot of
amplified library was diluted and grown on 200 Luria broth-ampicillin-supplemented plates (150-mm diameter), bacteria were
harvested, and plasmid DNA was purified using the Plasmid Giga kit
(Qiagen, Valencia, Calif.). Transfection and chromogenic reactions were
performed according to the manufacturer's protocol (Clontech).
Clones for yeast two-hybrid screens.
orf144
(EC27), 1629K (p78/83), and orf101 (C42) were
cloned into the yeast binding domain vector pAS2-1. Both
orf144 and orf101 were amplified from genomic
fragments using the appropriate PCR primers and cloned into pAS2-1 such
that the inserted gene was placed in frame using the EcoRI
site provided by the multicloning region. The fusion region for the
EC27 clone was
EFELGTRGS-Met-144, while the fusion for C42 was
EFR-Met-101 (fusion amino acids E and
F were provided by the EcoRI cloning site, and the first
amino acid encoded by the cloned gene is underlined). The resultant insert was fully sequenced to verify frame and to assure the fidelity of the polymerase reaction. A copy of the AcMNPV E2 strain
1629K gene was provided by C. Richardson (McGill University,
Montreal, Quebec, Canada [28]), and it was directly
subcloned into pAS2-1. The resultant clone had the Met start provided
by an NdeI site with an N-terminal His tag sequence; thus,
the fusion region was MHHHHHHLVPRGSGI-Thr-1629K.
Production of antibodies.
For C42, orf101 was
digested from pAS2-1 (described above) and cloned into pGEX 5X-1 using
a 5' EcoRI site and a 3' SalI site. The frame was
established by the EcoRI site; thus, the fusion site was
EFR-Met-101. The clone was transformed into BL21
cells, and protein was induced using 0.4 mM IPTG
(isopropyl-
-D-thiogalactopyranoside) and
either purified by excision from an SDS-polyacrylamide gel (denatured)
or purified using glutathione-agarose beads (native) according to the
manufacturer's instructions (Pharmacia Biotech, Arlington Heights,
Ill.). After antigen purification, three rabbits were injected for each
antigen (native or denatured). The first injection (intramuscular) was
approximately 200 µg of protein diluted with RIBI adjuvant
(MPL+TDM+CWS emulsion; RIBI Immunochem Research Inc., Hamilton,
Mont.). Two additional injections followed at 28-day intervals, and
each injection contained one-half the amount of the previous injection.
Twelve days after the third injection, the sera were tested, and 2 days
later, animals were exsanguinated and plasma was collected.
Microscopy. (i) Confocal analysis.
Sf9 cells were infected
(MOI, 10) and collected at the appropriate time. The harvested cells
were washed once with Grace's medium, and 2.1 × 105 cells were transferred and allowed to attach
to the slide using a one-well Cytofuge concentrator (StatSpin
Technologies, Norwood, Mass.). The cells were fixed with 3.7%
paraformaldehyde in PBS (20 mM phosphate, 140 mM NaCl, pH 7.2) for 10 min at room temperature. The cells were washed three times with PBS,
permeabilized by sequential treatments with methanol (10 min) and
Triton X-100 (0.5%, 10 min), and washed three times with PBS. The
cells were then blocked for 1 h with blocking solution (1%
chicken serum and 3% bovine serum albumin in PBS) and incubated
overnight at 4°C with primary antibody (C42; pAb 10910; 1:2,000).
Primary antibody was removed by washing three times with PBS, the cells
were then incubated with Alexa-488-linked anti-rabbit IgG for 2 h
(1:2,000; Molecular Probes, Eugene, Oreg.) and washed three times with
PBS, and DNA was stained with DAPI (4',6-diamidino-2-phenylindole; 0.1 µg/ml in PBS; 5 s). Cells were washed three times with PBS and
viewed with a Zeiss Axiovert CARV 135 confocal microscope. Hundreds of
cells were viewed, and approximately 15 fields of view containing 30 to
50 cells were collected, along with representative single cells.
Representative cells are shown. Z-stack sections were collected at
0.75-µm intervals. Deconvolution was performed using Zeiss KS 4.0 software.
(ii) Immunoelectron microscopy (IEM).
Sf9 cells were
infected (MOI, 20), and virus was adsorbed for 1 h, removed, and
replaced with complete medium. At the designated time p.i., cells were
pelleted and fixed and ultrathin sections were prepared for antibody
reactions as described by Hong et al. (11). Sections were
blocked with TTBS-bovine serum albumin (1%) for 1 h, reacted with
antibody (C42; pAb 10910; 1:1,000; overnight; 4°C), washed with
Tris-buffered saline, and reacted with secondary anti-rabbit,
gold-conjugated IgG (30 nm, 1:15 dilution; Electron Microscopy
Sciences, Washington, Pa.) for 1 h at room temperature. The
sections were stained with uranyl acetate (2) and lead citrate (27) and visualized with a Zeiss 10C transmission
electron microscope.
Blue native gel electrophoresis.
Blue native gel
electrophoresis was adapted from the work of Schagger and von Jagow
(24). Sf9 cells were infected (MOI, 20), collected at
28 h p.i. (2 × 107 cells per sample),
and washed with PBS, and the pellet was frozen until use. The pellet
was resuspended in water containing 200 U of DNase I, passed through a
27-gauge needle 10 times, sonicated for 45 s, and incubated on ice
for 2 h. The cells were then microcentrifuged (16,000 × g) for 10 min (4°C), and the soluble fraction
(supernatant) was transferred to a fresh tube and mixed with an equal
volume of 3× gel buffer (1.5 M aminocaproic acid, 150 mM
Bis-Tris, pH 7.0). To remove intact viral nucleocapsids, the
soluble fraction was centrifuged (100,000 × g, 30 min;
Beckman TLA100, 50,000 rpm), and to further remove large protein
complexes (i.e., ribosomes [30]), the soluble fraction
was collected and further centrifuged (400,000 × g, 15 min; Beckman TLA100, 95,000 rpm). The supernatant was collected, and
for every 200 µl of sample, 10 µl of dye was added (5% Serva Blue
G, 500 mM aminocaproic acid). A linear 6 to 13% acrylamide gradient
gel was generated (6%, 1.43 ml of 48:1.5 acrylamide:bisacrylamide, 4 ml of 3× gel buffer, 6.57 ml of H2O, 38 µl of
10% ammonium persulfate, 1.2 µl of TEMED
[N,N,N',N'-tetramethylethylenediamine]; 13%, 3.14 ml of acrylamide:bisacrylamide, 4 ml of 3× gel buffer, 2.4 ml of glycerol, 2.46 ml of H2O, 38 µl of 10%
ammonium persulfate, 12 µl of TEMED). After polymerization, the gel
was overlaid with a 4% stack (0.6 ml of acrylamide:bisacrylamide, 2.5 ml of 3× gel buffer, 4.33 ml of H2O, 60 µl of
10% ammonium persulfate, 6 µl of TEMED). The gel was run with the
cathode buffer containing 50 mM Tricine, 15 mM Bis-Tris, and 0.02%
Serva Blue G (pH 7.0) and the anode buffer containing 50 mM Bis-Tris,
pH 7.0. Samples were loaded (30 µl per well) and run at a constant
voltage (200 V) for 2 h, at which time the cathode buffer was
discarded and replaced with the same buffer minus Serva Blue G. The gel
was then run overnight at 4°C.
After completion, the gel was transferred to Immobilon P using Western
blotting procedures and probed with antibody (EC27, pAb 7351, 1:1,000;
C42, pAb 10910, 1:10,000; and p78/83 [provided by C. Richardson],
1:2,000). All primary antibody reactions were performed overnight
(4°C), secondary reactions were performed using the appropriate
secondary horseradish peroxidase-linked IgG antibody (1:10,000) for
2 h at room temperature, reaction mixtures were treated for 1 min
with Renaissance chemiluminescence reagent (NEN Life Science Products),
and positive reactions were detected by exposure to X-ray film.
 |
RESULTS |
orf101 is a late gene that codes for a highly
conserved 42-kDa structural protein of the baculovirus
nucleocapsid.
A homologue of orf101 is found in all the
baculovirus genome databases, including the most divergent genome,
Xestia c-nigrum granulovirus (Xc-n GV). A
comparison of the predicted amino acid sequences shows that several
regions of the orf101 gene product are highly conserved
among the nucleopolyhedroviruses (Fig.
1). Three conserved regions are
significant, the N-terminal region (amino acids 1 to 45) and amino
acids 130 to 200 and 280 to 360, and these regions share the highest
degree of conservation with Xc-n GV. A conserved classical
putative nuclear localization signal (KRKK) is located at the C
terminus of all the proteins (Fig. 1, asterisk) and SOSUI analysis
(10) predicts that the protein product of
orf101 would be soluble. The canonical binding motif for the
family of pocket proteins (pRB, p130, and p107 [reviewed in reference
9]) is found in the N-terminal conserved region of
AcMNPV and Bombyx mori nucleopolyhedrovirus
(LxCxE [Fig. 1, underlined]). This motif is not found in
Lymantria dispar nucleopolyhedrovirus, Orgyia
pseudotsugata nucleopolyhedrovirus (OpMNPV),
Spodoptera exigua nucleopolyhedrovirus, Helicoverpa
armigera nucleopolyhedrovirus, or Xc-n GV.

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 1.
Amino acid sequence comparison of orf101.
Identical amino acids of the nucleopolyhedroviruses are shaded and
outlined, while conservative changes are shown in shaded regions.
Because it is the most divergent, Xc-n GV C42 was
treated separately, and both identical and conserved amino acids are
shaded. The clones that were identified as interacting with
orf144 using yeast two-hybrid library screening are
noted with arrows above the sequence. The location of the LxCxE motif
(canonical binding sequence for pocket proteins) is underlined, while
the nuclear localization signal (KRKK) is noted with asterisks. Rules
used to assign conservation are as follows: A = G = S = T, V = L = I = M = F = Y = W, N = Q = D = E, and R = K = H. Accession numbers:
AcMNPV, L22858 (nucleotides 88004 to 86921);
BmMNPV (B. mori
nucleopolyhedrovirus), L33180 (nucleotides 81679 to 80591);
OpMNPV, U79530 (nucleotides 85649 to 85485);
LdMNPV (L. dispar
nucleopolyhedrovirus), U58676 (nucleotides 101348 to 100203);
SeMNPV (S. exigua
nucleopolyhedrovirus), AF169823 (nucleotides 61806 to 62972);
HaSNPV (H. armigera single
nucleopolyhedrovirus), AF271059 (nucleotides 82544 to 83653); and
Xc-n GV, AF162221 (nucleotides 86182 to 87300).
|
|
5'-primer extension analysis was performed to determine the temporal
pattern of orf101 transcription. Because three late
transcription initiation motifs (TAAG) are present from
80 to
254,
two primers were designed and tested using the appropriate sequencing
ladder to define nucleotide initiation sites; all primers gave the same results. In Fig. 2, use of a
representative analysis and the first ATG as the putative sequence for
translation initiation shows that all of the TAAG sequences serve as
initiation sites (
80,
164, and
254). Transcripts were detected at
18 h p.i., with levels increasing by 24 h p.i., and were
still detectable at 72 h p.i. There was an early consensus
initiation sequence (CAGT) located at
205, and the primer extension
results suggested that this site was recognized by 2 h p.i.;
thereafter, transcript levels decreased rapidly but were still
detectable at 24 h p.i. We report these data in Fig. 2 with a
question mark because trace amounts of transcripts of a similar size
were also detected in the uninfected control. The use of other primers,
various gel exposures, or increased amounts of RNA in the analysis did
not give more conclusive data. We conclude from this experiment that
orf101 is a late gene with transcripts being produced from
all three upstream TAAG motifs, and that transcripts may be produced at
low levels early in infection.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
Primer extension analysis of orf101.
Transcription initiation was mapped using 3 µg of mRNA isolated from
infected-cell extracts. Two oligonucleotides were used to accurately
assign nucleotide initiation sites, although only the results from
oligonucleotide 1 are shown here. The initiation sites of the extension
products are indicated to the right and in the sequence shown below.
Because of the high degree of amino acid sequence conservation (Fig.
1), the first ATG is tentatively assigned as the start codon.
|
|
orf101 was cloned into pGEX 5X-1, and rabbit polyclonal
antibodies to two fusion antigens (purified from SDS-polyacrylamide gels and purified in a nondenatured state using glutathione-agarose) were produced. Antibodies reacted with whole-cell lysates that were
collected throughout the time course of infection detected a
predominant band of 42 kDa (relative molecular mass) (Fig.
3, lanes 1 to 9) that correlated with the
predicted molecular mass for orf101 (41.5 kDa). This band
was detected at low levels by 12 h p.i., increased by 18 h
p.i., and continued to accumulate through 72 h p.i. A second band
of a lower molecular mass (relative molecular mass, 30 kDa) was also
detected during the time course, with the greatest accumulation
occurring late in infection (Fig. 3, lane 9). The quantity of the
lower-molecular-mass product varied when different preparations of
infected-cell lysates were analyzed, always showing the greatest amount
in cell lysates collected after 48 h p.i. We do not know if this
band represents alternate initiation from an internal methionine, a
degradation product, or a modified but functional form.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 3.
Temporal analysis of appearance and accumulation of C42.
Preparations of uninfected- and infected-cell extracts collected at
various times p.i. (noted above lanes 1 to 9) and purified BV and ODV
and respective envelope (ENV) and nucleocapsid (CAP) preparations were
separated by SDS-polyacrylamide gel electrophoresis, transferred to a
PVDF membrane, and tested with antisera to C42 (pAb 10910, 1:5,000).
Sample concentrations are noted on the bottom (micrograms), and
migration of molecular weight (MW; in thousands) markers is noted on
the right. The purity of the envelope and nucleocapsid preparations was
verified using antibodies to the marker proteins ODV-E66, gp67, and p39
(data not shown).
|
|
The 42-kDa protein was present in both purified BV and ODV (Fig. 3,
lanes 10 and 11). The amount of the 30-kDa form varied with the ODV
preparation, while BV preparations contained very small amounts, nearly
undetectable in most preparations (Fig. 3, lane 10). When ODV was
fractionated into envelope and nucleocapsid preparations, the 42-kDa
protein was detected only in the nucleocapsid fraction (Fig. 3, lanes
12 and 13), which was also true for BV (data not shown). The purity of
the viral fractionation was verified by using antibodies to the marker
proteins p39 (capsid), gp67 (BV-env), and ODV-E66 (ODV-env) (data not
shown). The product of orf101 is named BV/ODV-C42 (C42), to
reflect its relative molecular mass (42 kDa) and localization in the
nucleocapsids of BV and ODV.
Western blot analysis demonstrated that C42 was abundantly detected in
infected cells at 24 h p.i. (Fig. 3). At 24 h p.i., confocal
microscopy showed C42 to be predominantly located within the DNA-rich
virogenic stroma (Fig. 4, 24 h p.i.,
columns 1 to 5, white arrow). Low levels of C42 were also detected
within the cytoplasm, with this labeling most visible in the merged
view and the three-dimensional reconstruction of the Z sections (24 h
p.i., columns 3 and 5, yellow arrow). By 48 h p.i., the general character of C42 localization was at the edge of the virogenic stroma;
however, C42 was also detected in a more diffuse pattern throughout the
nucleus (Fig. 4, 48 h p.i., columns 1 to 5, arrow). By 72 h
p.i., C42 was detected throughout the nucleus with very little
associated with the virogenic stroma (Fig. 4, 72 h p.i., columns 1 to 5). The three-dimensional reconstruction shows the overall
representation of the cellular localization of C42 at each time point
(Fig. 4, column 5).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 4.
Confocal analysis of C42 localization in infected Sf9
cells. Infected Sf9 cells were collected at 24, 48, and 72 h p.i.
and reacted with primary antibody to C42 (pAb 10910) and secondary
antibody labeled with Alexa-488 IgG (Alexa-488; column 1). DNA was
stained using DAPI (column 2). The merged image includes Alexa-488 and
DAPI (column 3), while the bright-field image shows the gross structure
of the cell (column 4). Z-stack sections from representative cells are
shown, and column 5 shows a single view of the three-dimensional
reconstruction. The white arrow indicates the location of the virogenic
stroma, while the yellow arrow (24 h p.i., columns 3 and 4) shows the
cytoplasmic label of C42.
|
|
Fine-structure localization of C42 (IEM) at 48 h p.i. detected
gold-labeled clusters of C42 at the periphery and clear areas within
the virogenic stroma (Fig. 5B, arrow),
while less label was detected in association with the virogenic stroma
at 72 h p.i. (Fig. 5C, arrow). These data are consistent with
observations generated using confocal microscopy. Gold-labeled C42 was
detected with nucleocapsids of ODV (Fig. 5D, arrow); this label was
easier to see when the ODV nucleocapsids were grouped in the process of
being occluded (Fig. 5E, arrow) or in mature occlusions (Fig. 5F,
arrows). The preimmune serum control showed limited background cross-reactivity when tested against infected cells (Fig. 5A).

View larger version (122K):
[in this window]
[in a new window]
|
FIG. 5.
IEM analyses of C42 localization in infected Sf9 cells.
Infected Sf9 cells were collected at 24, 48, and 72 h p.i. and
processed for IEM. Primary antibody was C42 (pAb 10910), and secondary
antibody was anti-rabbit 30-nm-gold-labeled IgG. (A) Preimmune control
serum (48 h p.i.). (B and C) Labeling of virogenic stroma (48 h p.i.
[B] and 72 h p.i. [C]). (D to F) Labeling of C42 at the
nucleocapsid of ODV (48 h p.i.). Size designations are in micrometers.
Arrows show immunogold labeling of C42.
|
|
C42 is present in a complex with p78/83 and EC27.
orf101 (C42) was first drawn to our attention when a yeast
two-hybrid screen of infected-cell cDNA libraries (18 and 24 h p.i.), using orf144 (EC27) as bait, identified eight
interacting clones encoded by orf101 (noted in Fig. 1,
arrows). In a similar screen, when 1629K (p78/83) was used
as bait to probe a 24 h-p.i. Sf9 cDNA library, this screen identified
orf101 (C42) seven times. Sequence analysis showed that all
seven orf101 library clones started at the first methionine.
To confirm the yeast two-hybrid predictions that C42:EC27 and
C42:p78/83 interact directly to form complexes, we needed a procedure
that would (i) identify protein interactions which occur prior to virus
assembly and/or (ii) remove assembled nucleocapsids and virus, while
retaining conditions that allow protein complexes to remain intact. For this, we used blue native electrophoresis. This technique separates both acidic and basic protein complexes and provides a tentative assignment of the complex's molecular mass (17, 23, 24). We chose to use a 28-h-p.i. infected-cell sample because EC27, C42, and
p78/83 are present, and studies using other viral structural proteins
(ODV-E66, ODV-E25, and FP25K) show that these proteins are being
translated at their maximal rate (20). Figure
6A gives a summary of sample preparation.
After infected cells were harvested, DNA was degraded (DNase,
sonication, and shear forces), and virus, nucleocapsids (100,000 × g), and very large complexes (e.g., ribosomes, 400,000 × g [30]) were removed by
sequential centrifugation. All fractions were analyzed, and C42 was
detected primarily in the 400,000 × g soluble fraction
(Fig. 6A, asterisk). The blue native gel analysis of this fraction is
shown in Fig. 6B. A complex with an approximate molecular mass of 500 to 600 kDa which was immunoreactive with antibodies to C42 (lane 2),
p78/83 (lane 4), and EC27 (lane 6) was detected. Additionally,
complexes showing positive interactions between C42 and p78/83 were
also detected at lower masses, with the most prominent of these being
at ~180 kDa (lanes 2 and 4, circle). This experiment was repeated
three times with cell extracts isolated from different infections, and the immunoreactive profiles were the same. To confirm the specificity of the interactions detected by native gel electrophoresis, we performed control antibody reactions with E66, FP25K, and E25, and none
of these antibodies were detected in complexes with molecular masses
corresponding to those shown in Fig. 6 (data not shown). We note that
the antibody to EC27 strongly reacts to a cellular complex at
approximately 140 kDa; however, we do not know the significance of this
observation.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 6.
Native gel electrophoresis. (A) Summary overview of
purification protocol of 28-h-p.i. infected-cell extracts. (B) The
samples of the soluble fraction were separated using blue native
electrophoresis, blotted onto a PVDF membrane, and probed with the
indicated antibody. Arrows point to a complex containing EC27, C42, and
p78/83, while the circles show a complex containing only C42 and
p78/83. U, uninfected-cell lysate; I, infected-cell lysate. Approximate
molecular masses are indicated on the left (kilodaltons).
|
|
 |
DISCUSSION |
Transcriptional analyses show that orf101 is a late
gene with maximal levels of transcripts accumulating at 24 h p.i.
(Fig. 2). This agrees with the data of Russell and Rohrmann
(22) showing that, during infection by OpMNPV,
p40 (orf3, the gene homologue to AcMNPV
orf101) transcripts are detected at 24 h p.i.,
steady-state transcript levels decrease by 36 h p.i., and
transcription initiates from a conserved TAAG sequence. Our study
suggests that, if transcripts are made early during infection (CAGT),
their steady-state levels are low and protein accumulation is not
detectable (Fig. 2 and 3). orf101 encodes a protein with a
relative molecular mass of 42 kDa that is a component of both BV and
ODV nucleocapsid (Fig. 2 and 3). We have designated this gene product
BV/ODV-C42 (C42).
C42 is conserved among baculoviruses and contains a classical nuclear
localization sequence located at the C terminus (Fig. 1). Consistent
with the presence of this motif, C42 is predominantly detected within
the infected-cell nucleus. At 24 h p.i., C42 is associated with
the virogenic stroma; by 48 h p.i., it locates at the edge of the
stroma; and at later time points, it is located in a dispersed pattern
throughout the nucleus which is consistent with its incorporation into
ODV (Fig. 4). These observations were confirmed by IEM, which shows the
localization of C42 within the virogenic stroma and the nucleocapsid of
the virion (Fig. 5).
Yeast two-hybrid analysis, using orf144 as bait, identified
eight interacting clones containing truncated orf101 (C42).
Sequence analysis showed that these corresponded to four independent
clones of orf101, and the details of these clones are shown
in Fig. 1. Yeast two-hybrid screens using 1629K (p78/83) as
bait also identified orf101 seven times, and sequence
analysis revealed that these represented the same clone, all containing
the methionine start codon for C42. To confirm that the interactions
predicted by yeast two-hybrid analysis reflected interactions which
occurred in vivo, blue native gel and Western blot analysis was
performed using fractions prepared from infected cells (28 h p.i.).
This analysis showed that C42 and p78/83 (p78/83 is also a structural
protein of baculovirus [18, 21]) comigrate, consistent
with complex formation, and that they are present in two complexes, a
complex at 180 kDa and a larger complex (approximately 500 to 600 kDa) that also contains EC27.
The primary sequence of AcMNPV C42 contains the canonical
binding motif of the pocket proteins (LxCxE). Interaction of viral proteins with pocket proteins (pRB, p130, and p107) plays an essential role in viral infectivity of other viruses. Simian virus 40 T, human
papillomavirus E7, and adenovirus E1A (reviewed in reference 9) interact with pocket proteins to stimulate activity of
the transcription factor E2F. Indeed, mutations within the pRB binding motif of the rubella virus gene NSP90 decreased viral DNA replication to <0.5%, while deletion of the motif was lethal (8). If
such a mechanism is utilized by baculoviruses, one might predict that the pocket protein binding motif of C42 would be conserved among all
baculoviruses; however, genome sequences show that this is not the case
(Fig. 1). Thus, if C42 functionally interacts with pocket proteins, it
is possible that it also performs other functions, that this function
is host specific, or that other viruses and/or viral genes encode
proteins with analogous function. Other examples of control of cell
cycle and viral DNA replication by viruses include the coding of
cellular cyclin homologues. Human herpesvirus (k-cyclin
[6]), herpesvirus saimiri (v-cyclin
[12]), murine gammaherpesvirus 68 (m-cyclin
[29]), and walleye fish dermal sarcoma retrovirus
(16) all encode cyclin-like proteins. The viral k- and
v-cyclins complex with cdk6, increase the resistance of
cyclin-dependent kinases to inhibitors, and enhance substrate range,
and the viral cyclin-cdk6 complex directly triggers the initiation of
DNA synthesis in isolated late-G1 nuclei
(15).
It is possible that C42, EC27, and p78/83 together, or individually,
interact with cellular components to generate an S-phase-like environment and stimulate in vivo DNA replication. Like the putative interaction of EC27 with cellular cyclin kinases, interaction of C42
with the pocket family of proteins would be a good candidate for
regulation of the cell cycle and may play a direct role in viral DNA
replication in vivo. Current studies are focused on more fully
understanding the nature and function of the viral protein complexes
containing EC27, C42, and p78/83 and determining if C42 functionally
interacts with pocket proteins. Such interactions would strongly
suggest that AcMNPV presents proteins (as part of its
structural composition) that interact with cellular regulatory proteins
immediately upon infection. These interactions likely play a critical
role in regulating the cell cycle and enhancing viral infectivity.
 |
ACKNOWLEDGMENTS |
We thank Gabriela Marcano and Shawn Williamson for the
development of the yeast two-hybrid cDNA libraries and Bridget Sweeney and Erin Pickerton for the library screens. We thank C. Richardson (Amgen Institute, Toronto, Ontario, Canada) for providing antibodies to
p78/83 and a plasmid containing the 1629K gene and Tina
Heyman and Jared Burks for their expert assistance with confocal
microscopy. Electron microscopy was performed using the facilities of
the Electron Microscopy Center at Texas A&M University.
This work was supported in part by National Institutes of Health grant
2RO1GM47552 (M.D.S. and S.C.B.) and Texas Agricultural Experiment
Station project TEXO8078 (M.D.S.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Entomology, Texas A&M University, College Station, TX 77843-2475. Phone: (979) 847-9036. Fax: (979) 845-8934. E-mail:
m-summers{at}tamu.edu.
 |
REFERENCES |
| 1.
|
Belyavskyi, M.,
S. C. Braunagel, and M. D. Summers.
1998.
The structural protein ODV-EC27 of Autographa californica nucleopolyhedrovirus is a multifunctional viral cyclin.
Proc. Natl. Acad. Sci. USA
95:11205-11210[Abstract/Free Full Text].
|
| 2.
|
Bozzola, J. J., and L. D. Russell.
1992.
Electron microscopy.
Jones and Bartlett, Boston, Mass.
|
| 3.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[CrossRef][Medline].
|
| 4.
|
Braunagel, S. C.,
R. Parr,
M. Belyavskyi, and M. D. Summers.
1998.
Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
Virology
244:195-211[CrossRef][Medline].
|
| 5.
|
Braunagel, S. C., and M. D. Summers.
1994.
Autographa californica nuclear polyhedrosis virus, PDV, and ECV viral envelopes and nucleocapsids: structural proteins, antigens, lipid and fatty acid profiles.
Virology
202:315-328[CrossRef][Medline].
|
| 6.
|
Chang, Y.,
P. S. Moore,
S. J. Talbot,
C. H. Boshoff,
T. Zarkowska,
D. Godden-Kent,
H. Paterson,
R. A. Weiss, and S. Mittnacht.
1996.
Cyclin encoded by KS herpesvirus.
Nature (London)
382:410[CrossRef][Medline].
|
| 7.
|
Dow, J. A. T.
1986.
Insect midgut function.
Adv. Insect Physiol.
19:197-328.
|
| 8.
|
Forng, R.-Y., and C. D. Atreya.
1999.
Mutations in the retinoblastoma protein-binding LXCXE motif of rubella virus putative replicase affect virus replication.
J. Gen. Virol.
80:327-332[Abstract].
|
| 9.
|
Funk, J. O., and D. A. Galloway.
1998.
Inhibiting CDK inhibitors: new lessons from DNA tumor viruses.
Trends Biochem. Sci.
23:337-341[CrossRef][Medline].
|
| 10.
|
Hirokawa, T.,
S. Boon-Chieng, and S. Mitaku.
1998.
SOSUI: classification and secondary structure prediction system for membrane proteins.
Bioinformatics
14:378-379[Abstract/Free Full Text].
|
| 11.
|
Hong, T.,
S. C. Braunagel, and M. D. Summers.
1994.
Transcription, translation, and cellular localization of PDV-E66: a structural protein of the PDV envelope of Autographa californica nuclear polyhedrosis virus.
Virology
204:210-222[CrossRef][Medline].
|
| 12.
|
Jung, J. U.,
M. Stager, and R. C. Desrosiers.
1994.
Virus-encoded cyclin.
Mol. Cell. Biol.
14:7235-7244[Abstract/Free Full Text].
|
| 13.
|
Keddie, B. A.,
G. W. Aponte, and L. E. Volkman.
1989.
The pathway of infection of Autographa californica nuclear polyhedrosis virus in an insect host.
Science
243:1728-1730[Abstract/Free Full Text].
|
| 14.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[CrossRef][Medline].
|
| 15.
|
Laman, H.,
D. Coverly,
T. Krude,
R. Laskey, and N. Jones.
2001.
Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication.
Mol. Cell. Biol.
21:624-635[Abstract/Free Full Text].
|
| 16.
|
LaPierre, L. A.,
J. W. Casey, and D. L. Holzschu.
1998.
Walleye retroviruses associated with skin tumors and hyperplasias encode cyclin D homologs.
J. Virol.
72:8765-8771[Abstract/Free Full Text].
|
| 17.
|
Neff, D., and N. A. Dencher.
1999.
Purification of multisubunit membrane protein complexes: isolation of chloroplast FoF1-ATP synthase, Cfo and CF1 by blue native electrophoresis.
Biochem. Biophys. Res. Commun.
259:569-575[CrossRef][Medline].
|
| 18.
|
Pham, D. Q.-D.,
R. H. Hice,
N. Sivasubramanian, and B. A. Federici.
1993.
The 1629-bp open reading frame of the Autographa californica multinucleocapsid polyhedrosis virus encodes a virion structural protein.
Gene
137:275-280[CrossRef][Medline].
|
| 19.
|
Prikhod'ko, E. A., and L. K. Miller.
1998.
Role of baculovirus IE2 and its RING finger in cell cycle arrest.
J. Virol.
72:684-692[Abstract/Free Full Text].
|
| 20.
|
Rosas-Acosta, G.,
S. C. Braunagel, and M. D. Summers.
2001.
Effects of deletion and overexpression of the Autographa californica nuclear polyhedrosis virus FP25K gene on synthesis of two occlusion-derived virus envelope proteins and their transport into virus-induced intranuclear membranes.
J. Virol.
75:10829-10842[Abstract/Free Full Text].
|
| 21.
|
Russell, R. L. Q.,
C. J. Funk, and G. F. Rohrmann.
1997.
Association of a baculovirus-encoded protein with the capsid basal region.
Virology
227:142-152[CrossRef][Medline].
|
| 22.
|
Russell, R. L. Q., and G. F. Rohrmann.
1990.
The p6.5 gene region of a nuclear polyhedrosis virus of Orgyia pseudotsugata: DNA sequence and transcriptional analysis of four late genes.
J. Gen. Virol.
71:551-560[Abstract/Free Full Text].
|
| 23.
|
Schagger, H.,
W. A. Cramer, and G. von Jagow.
1994.
Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis.
Anal. Biochem.
217:220-230[CrossRef][Medline].
|
| 24.
|
Schagger, H., and G. von Jagow.
1991.
Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form.
Anal. Biochem.
199:223-231[CrossRef][Medline].
|
| 25.
|
Summers, M. D., and K. Egawa.
1973.
Physical and chemical properties of Trichoplusia ni granulosis virus granulin.
J. Virol.
12:1092-1103[Abstract/Free Full Text].
|
| 26.
|
Summers, M. D., and G. E. Smith.
1987.
A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiment Station Bulletin 1555.
Texas A&M University, College Station.
|
| 27.
|
Venable, J. H., and R. Coggeshall.
1965.
A simplified lead citrate stain for use in electron microscopy.
J. Cell Biol.
25:407-408[Free Full Text].
|
| 28.
|
Vialard, J. E., and C. D. Richardson.
1993.
The 1,629-nucleotide open reading frame located downstream of the Autographa californica nuclear polyhedrosis virus polyhedrin gene encodes a nucleocapsid-associated phosphoprotein.
J. Virol.
67:5859-5866[Abstract/Free Full Text].
|
| 29.
|
Virgin, H. W.,
P. Latreille,
P. Wamsley,
K. Hallsworth,
K. E. Weck,
A. J. Dal Canto, and S. H. Speck.
1997.
Complete sequence and genomic analysis of murine gammaherpesvirus 68.
J. Virol.
71:5894-5904[Abstract].
|
| 30.
|
Wang, L., and B. Dobberstein.
1999.
Oligomeric complexes involved in translocation of proteins across the membrane of the endoplasmic reticulum.
FEBS Lett.
457:316-322[CrossRef][Medline].
|
| 31.
|
Washburn, J. O.,
B. A. Kirkpatrick, and L. E. Volkman.
1995.
Comparative pathogenesis of Autographa californica M nuclear polyhedrosis virus in larvae of Trichoplusia ni and Heliothis virescens.
Virology
209:561-568[CrossRef][Medline].
|
Journal of Virology, December 2001, p. 12331-12338, Vol. 75, No. 24
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.12331-12338.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, Y., Wang, Q., Liang, C., Song, J., Li, N., Shi, H., Chen, X.
(2008). Autographa californica Multiple Nucleopolyhedrovirus Nucleocapsid Protein BV/ODV-C42 Mediates the Nuclear Entry of P78/83. J. Virol.
82: 4554-4561
[Abstract]
[Full Text]
-
Fang, M., Dai, X., Theilmann, D. A.
(2007). Autographa californica Multiple Nucleopolyhedrovirus EXON0 (ORF141) Is Required for Efficient Egress of Nucleocapsids from the Nucleus. J. Virol.
81: 9859-9869
[Abstract]
[Full Text]
-
Deng, F., Wang, R., Fang, M., Jiang, Y., Xu, X., Wang, H., Chen, X., Arif, B. M., Guo, L., Wang, H., Hu, Z.
(2007). Proteomics Analysis of Helicoverpa armigera Single Nucleocapsid Nucleopolyhedrovirus Identified Two New Occlusion-Derived Virus-Associated Proteins, HA44 and HA100. J. Virol.
81: 9377-9385
[Abstract]
[Full Text]
-
Braunagel, S. C., Russell, W. K., Rosas-Acosta, G., Russell, D. H., Summers, M. D.
(2003). Determination of the protein composition of the occlusion-derived virus of Autographa californica nucleopolyhedrovirus. Proc. Natl. Acad. Sci. USA
100: 9797-9802
[Abstract]
[Full Text]